IR00401 利血平(10mM in DMSO,无菌) 跨膜转运/离子通道 索莱宝

IR00401 利血平(10mM in DMSO,无菌) 跨

膜转运/离子通道 索莱宝
收藏
  • ¥360
  • Solarbio已认证
  • 北京
  • IR00401
  • 2025年07月23日
    avatar
    品牌商
    13钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 技术资料
    • 保存条件

      Stroe at -20℃,6 months.

    • 保质期

      Stroe at -20℃,6 months.

    • 英文名

      Reserpine(10mM in DMSO,Sterile)

    • 库存

      现询

    • 供应商

      北京索莱宝科技有限公司

    • CAS号

      50-55-5

    • 规格

      1ml

    基本信息
    CASNo.50-55-5
    中文名称利血平(10mM in DMSO,无菌)
    英文名称Reserpine(10mM in DMSO,Sterile)
    分子式C33H40N2O9
    分子量608.68
    溶解性请根据自己的实验要求使用。
    外观(性状)无菌溶液
    储存条件Stroe at -20℃,6 months.
    靶点VMAT2
    通路Membrane Transporter&Ion Channel
    背景说明Reserpine 是囊泡单胺转运蛋白 2 (VMAT2) 的抑制剂。
    生物活性Reserpine is an inhibitor of the vesicular monoamine transporter 2 (VMAT2).[1]
    In VitroReserpine is an inhibitor of the vesicular monoamine transporter 2 (VMAT2). Reserpine displays a significant effect on the density of dopamine D1 receptors (F2,12=8.81, p[1]. IC50 values of 43.9 and 54.9 μM are obtained after 1 day of treatment with Reserpine in JB6 P+ and HepG2-C8 cells, respectively. Reserpine induces luciferase activity in a dose-dependent manner at concentrations ranging from 5 to 50 μM, and no significant induction is observed at concentrations lower than 5 μM. Results demonstrate that Reserpine (2.5 to 10 μM) also increases the protein expression of Nrf2, HO-1, and NQO1. Reserpine at concentrations of 2.5 to 10 μM decreases the mRNA expression of DNMT1, DNMT3a, and DNMT3b in a concentration-dependent manner in JB6 P+ cells after 7 days of treatment. Reserpine at 10 μM generates a significant difference for DNMT3a expression (p[2].
    细胞实验JB6 P+ cells are seeded in 96-well plates containing Minimum essential media (MEM) at a density of 1×104 cells/mL (100 μL/well) for 1, 3, and 5 days, and HepG2-C8 cells are seeded in plates containing DMEM. After incubation for 24 h, the cells are treated with either DMSO or various concentrations of Reserpine. For JB6 P+ cells, the medium is changed every 2 days for the 3-day and 5-day treatments. Cell viability is assessed using a MTS assay kit according to the manufacturer’s instructions. The absorbance of the formazan product is read at 490 nm, and the cell viability is calculated and compared with the DMSO control group[2].
    动物实验Albino rats of either sex weighing between 100 to 150 g are used in the study. They are acclimatized to the laboratory conditions for at least 10 days prior to the experiment and provided with standard diet and water ad libitum with 12 h light and dark cycle. Animals are divided into different groups of six each and are housed individually in metabolic cages. Group 1: Control animals treated with DMSO intraperitoneally at a dose of 0.1 mL/100 g body weight. Group 2: Animals administered intraperitoneally with Reserpine at a dose of 5 mg/kg body weight. The 24 h urine samples from the point of drug administration are collected for each animal[3].
    激酶实验After incubation for 24 h, JB6 P+ cells (1×105 cells/10-cm dish) are treated with various concentrations of Reserpine. Whole cell lysates are prepared from the treated cells using radioimmunoprecipitation assay buffer supplemented with a protease inhibitor cocktail, and a BCA kit is used to determine protein concentrations[2].
    数据来源文献[1]. Antkiewicz-Michaluk L, et al. Withdrawal from repeated administration of a low dose of reserpine induced opposing adaptive changes in the noradrenaline and serotonin system function: a behavioral and neurochemical ex vivo and in vivo studies in the rat. Prog Neuropsychopharmacol Biol Psychiatry. 2015 Mar 3;57:146-54.
    [2]. Hong B, et al. Reserpine Inhibit the JB6 P+ Cell Transformation Through Epigenetic Reactivation of Nrf2-Mediated Anti-oxidative Stress Pathway. AAPS J. 2016 May;18(3):659-69.
    [3]. Sreemantula S, et al. Reserpine methonitrate, a novel quaternary analogue of reserpine augments urinary excretion of VMA and 5-HIAA without affecting HVA in rats. BMC Pharmacol. 2004 Nov 16;4:30.
    单位

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥260
    北京索莱宝科技有限公司
    2025年07月05日询价
    ¥1720
    上海研卉生物科技有限公司
    2025年10月16日询价
    询价
    北京诺博莱德科技有限公司
    2025年11月19日询价
    询价
    上海雅心生物技术有限公司
    2025年12月26日询价
    ¥135
    翌圣生物科技(上海)股份有限公司
    2025年10月19日询价
    IR00401 利血平(10mM in DMSO,无菌) 跨膜转运/离子通道 索莱宝
    ¥360